Shanmuga Hos.

Why is Shanmuga Hospital Ltd falling/rising?

As of 18-Jul, Shanmuga Hospital Ltd's stock price is stable at Rs 47.65, despite a recent trend reversal and a 1.71% underperformance against its sector. Long-term performance remains positive with a 1-month rise of 28.78%, and increased investor interest is indicated by a 97.37% rise in delivery volume.

As of 18-Jul, Shanmuga Hospital Ltd's stock price is currently stable at Rs 47.65, showing no change from the previous trading session. However, the stock has recently experienced a trend reversal, having fallen after two consecutive days of gains. Today, it underperformed its sector by 1.71%, and it touched an intraday low of Rs 47.04, representing a decline of 2.2%.<BR><BR>Despite these short-term fluctuations, the stock has shown positive performance over longer periods, with a 1-week increase of 3.14% and a significant 1-month rise of 28.78%. Additionally, Shanmuga Hospital Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend in the stock's price over time.<BR><BR>Investor participation has also increased, with delivery volume rising by 97.37% against the 5-day average, suggesting growing interest in the stock. However, the current performance indicates a temporary setback, likely influenced by the recent price movements and market conditions.

Which are the latest news on Shanmuga Hos.?

What does Shanmuga Hos. do?

Shanmuga Hospital Limited is a micro-cap company in the hospital industry, originally incorporated in 2020 and later converted to a public company. It has a market cap of INR 48 Cr, with key metrics including a P/E ratio of 12.00 and a debt-equity ratio of 0.11.

Overview: <BR>Shanmuga Hospital Limited operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Shanmuga Hospital Limited was originally incorporated as a Private Limited Company under the name "Shanmuga Hospital Private Limited" on June 26, 2020. It later converted to a Public Company, resulting in a name change to "Shanmuga Hospital Limited." Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 48 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 12.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.11 <BR>Return on Equity: 9.91% <BR>Price-to-Book: 1.13 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Shanmuga Hos.?

Summary could not be generated.

As of 10th June, Shanmuga Hospital Ltd has a market capitalization of 48.00 Cr, categorized as a Micro Cap.<BR><BR>Recent quarterly performance data is unavailable, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 39.70 Cr and Total Assets valued at 52.78 Cr.

Who are the peers of the Shanmuga Hos.?

Shanmuga Hos. peers include Fortis Malar, Soni Medicare, KK Shah Hospital, Sangani Hospital, Aatmaj Health, Nephro Care, Nidan Laborator., and KHFM Hospitality. Shanmuga Hos. has excellent management and capital structure, with a 1-year return of -2.27%, better than Fortis Malar but worse than Soni Medicare's 43.70%.

Peers: The peers of Shanmuga Hos. are Fortis Malar, Soni Medicare, KK Shah Hospital, Sangani Hospital, Aatmaj Health, Maitreya Medica., Nephro Care, Nidan Laborator., KHFM Hospitality.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shanmuga Hos., while Average management risk is found at Aatmaj Health and Nephro Care, and the rest have Below Average management risk. Growth is Excellent at Sangani Hospital and Nephro Care, Average at Shanmuga Hos. and Aatmaj Health, and the rest have Below Average growth. Capital Structure is Excellent at Shanmuga Hos., Good at KK Shah Hospital, Sangani Hospital, Aatmaj Health, and Nephro Care, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: Soni Medicare has the highest 1-year return at 43.70%, while Fortis Malar has the lowest at -29.66%. Shanmuga Hos. has a 1-year return of -2.27%, which is better than Fortis Malar but worse than Soni Medicare. Additionally, peers with negative six-month returns include Fortis Malar and Shanmuga Hos.

Is Shanmuga Hos. overvalued or undervalued?

As of December 4, 2025, Shanmuga Hospitals is considered very expensive and overvalued with a PE ratio of 15.62, despite outperforming the Sensex with an 8.66% return, while its valuation remains elevated compared to peers like Max Healthcare and Apollo Hospitals.

As of 4 December 2025, the valuation grade for Shanmuga Hospitals has moved from expensive to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 15.62, an EV to EBITDA of 8.71, and a ROCE of 12.75%. <BR><BR>In comparison to its peers, Shanmuga Hospitals' PE ratio is substantially lower than that of Max Healthcare, which stands at 74.46, and Apollo Hospitals at 61.81, both of which are categorized as very expensive and attractive, respectively. Despite this, the company's valuation remains elevated relative to its industry peers. Notably, Shanmuga Hospitals has outperformed the Sensex over the past month, with a stock return of 8.66% compared to the Sensex's 2.16%, reinforcing the notion of its current overvaluation.

How has been the historical performance of Shanmuga Hos.?

Shanmuga Hos. has shown steady growth in net sales, increasing from 39.34 Cr in Mar'23 to 47.85 Cr in Mar'25, but experienced a decline in operating profit and net income, with profit after tax falling to 4.21 Cr in Mar'25. Despite rising total assets to 52.78 Cr, cash flow from operating activities turned negative at -12.00 Cr in Mar'25.

Answer:<BR>The historical performance of Shanmuga Hos. shows a steady increase in net sales over the past three years, rising from 39.34 Cr in Mar'23 to 43.04 Cr in Mar'24, and reaching 47.85 Cr in Mar'25. The total operating income mirrored this trend, with a consistent increase to 47.85 Cr in Mar'25. However, the operating profit (PBDIT) has seen a slight decline from 8.95 Cr in Mar'24 to 8.47 Cr in Mar'25, despite an increase in other income. Profit before tax also decreased from 7.02 Cr in Mar'24 to 5.69 Cr in Mar'25, leading to a profit after tax of 4.21 Cr in Mar'25, down from 5.25 Cr in Mar'24. The earnings per share (EPS) reflected this decline, dropping to 3.09 in Mar'25 from 5.36 in Mar'24. On the balance sheet, total assets increased significantly from 33.92 Cr in Mar'24 to 52.78 Cr in Mar'25, driven by a rise in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, resulting in a stronger equity position with shareholder's funds increasing to 39.70 Cr in Mar'25. Cash flow from operating activities turned negative in Mar'25 at -12.00 Cr, contrasting with a positive cash flow of 9.00 Cr in Mar'24, while financing activities provided a net inflow of 16.00 Cr in Mar'25.<BR><BR>Breakdown:<BR>Shanmuga Hos. has demonstrated a positive trend in net sales, which increased from 39.34 Cr in Mar'23 to 47.85 Cr in Mar'25. Despite this growth in revenue, the operating profit (PBDIT) has slightly declined, indicating rising costs, particularly in employee expenses and other expenses, which totaled 39.61 Cr in Mar'25. The profit before tax decreased to 5.69 Cr in Mar'25, resulting in a profit after tax of 4.21 Cr. The company's equity capital and reserves have significantly improved, with total reserves reaching 26.09 Cr in Mar'25, contributing to a total shareholder's fund of 39.70 Cr. The total assets have also increased to 52.78 Cr, primarily due to higher cash and bank balances, while total liabilities rose to 7.61 Cr. However, cash flow from operating activities has turned negative, highlighting potential liquidity challenges despite a positive cash flow from financing activities.

Who are the top shareholders of the Shanmuga Hos.?

The top shareholders of Shanmuga Hos. include Panneerselvam Prabu Sankar with 18.01%, and individual investors who own 24.48%. Notably, there are no pledged promoter holdings, and the largest public shareholder is Black Fox Financial Private Limited with 1.41%.

The top shareholders of Shanmuga Hos. primarily consist of promoters, with Panneerselvam Prabu Sankar holding the largest stake at 18.01%. There are no pledged promoter holdings, indicating a strong commitment from the promoters. In terms of institutional investors, there is one Foreign Institutional Investor (FII) holding a small stake of 0.19%. The highest public shareholder is Black Fox Financial Private Limited, which holds 1.41%. Additionally, individual investors collectively own 24.48% of the company.

When is the next results date for Shanmuga Hos.?

No Upcoming Board Meetings

Has Shanmuga Hos. declared dividend?

No Dividend History Available